Dementia Therapy
Reports from University of Pittsburgh, Western Psychiatric Institute describe recent advances in dementia therapy
Published in Mental Health Law Weekly, March 13th, 2010
Investigators publish new data in the report 'Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.' "The risk/benefit ratio of pharmacotherapy for behavioral symptoms of dementia is questionable: second-generation antipsychotics are poorly tolerated, and the efficacy of alternative treatments, for example, selective serotonin-reuptake inhibitors (SSRIs), is uncertain. Biomarkers of treatment response may improve this risk/benefit ratio," scientists in the United States report.
"The length polymorphism of the serotonin transporter promoter gene (5-HTTLPR/SLC6A4) may moderate tolerability of SSRIs and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
More Articles from Mental Health Law Weekly
- Alcohol Monitoring Systems, Inc.
St. Louis County Tests Alcohol Bracelets, Awards Contract to EMASS and SCRAM - Arizona Conference of Police and Sheriffs
Arizona Public Safety Officials and Community Organizations Denounce Gov. Brewer's Plan to Eliminate Arizona Department of Juvenile Corrections - Connectyx Technologies Holdings Group Inc.
Connectyx Sponsors Darryl Strawberry Foundation for Autism at NY Islanders Event at Nassau Veterans Memorial Coliseum - Diagnostics
Studies from Oklahoma State University, Department of Psychology reveal new findings on diagnostics - Eating Disorders
Studies from Harvard University yield new data on eating disorder in adolescents - Gender and Health
New gender and health study findings have been reported by scientists at Florida State University - More from this issue of Mental Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
